These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9366101

  • 1. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].
    Meilhac B, Montestruc F, Aubin F, Djian F, Rouffy J.
    Therapie; 1997; 52(3):179-86. PubMed ID: 9366101
    [Abstract] [Full Text] [Related]

  • 2. Naftidrofuryl in quality of life (NIQOL). A Belgian study.
    D'Hooge D, Lehert P, Clement DL.
    Int Angiol; 2001 Dec; 20(4):288-94. PubMed ID: 11782694
    [Abstract] [Full Text] [Related]

  • 3. A new study demonstrates the efficacy of naftidrofuryl in the treatment of intermittent claudication. Findings of the Naftidrofuryl Clinical Ischemia Study (NCIS).
    Kieffer E, Bahnini A, Mouren X, Gamand S.
    Int Angiol; 2001 Mar; 20(1):58-65. PubMed ID: 11342997
    [Abstract] [Full Text] [Related]

  • 4. Treatment of stage II chronic arterial disease of the lower limbs with the serotonergic antagonist naftidrofuryl: results after 6 months of a controlled, multicenter study.
    Adhoute G, Andreassian B, Boccalon H, Cloarec M, Di Maria G, Lefebvre O, Mondine P, Plagnol P, Pointel JP, Quancard X.
    J Cardiovasc Pharmacol; 1990 Mar; 16 Suppl 3():S75-80. PubMed ID: 1369725
    [Abstract] [Full Text] [Related]

  • 5. [Consequences of obliterating arteriopathy of the legs on the professional activity of patients and external assistance].
    Rolland N, Lebrun T, Comte S, Sailly JC.
    J Mal Vasc; 1999 Jun; 24(3):208-13. PubMed ID: 10467531
    [Abstract] [Full Text] [Related]

  • 6. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
    Kakkos SK, Geroulakos G, Nicolaides AN.
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 8. Health-related quality of life after revascularization for peripheral arterial occlusive disease: long-term follow-up.
    Wann-Hansson C, Hallberg IR, Risberg B, Lundell A, Klevsgard R.
    J Adv Nurs; 2005 Aug; 51(3):227-35. PubMed ID: 16033590
    [Abstract] [Full Text] [Related]

  • 9. Findings of the Naftidrofuryl in Quality of Life (NIQOL) European study program.
    Spengel F, Clément D, Boccalon H, Liard F, Brown T, Lehert P.
    Int Angiol; 2002 Mar; 21(1):20-7. PubMed ID: 11941270
    [Abstract] [Full Text] [Related]

  • 10. Nicergoline in the treatment of dizziness in elderly patients. A review.
    Felisati G, Pignataro O, Di Girolamo A, Bruno E, Alessandrini M, Guidetti G, Monzani D, Beldi AM, Mira E, Benazzo M, Pallestrini E, Caligo G, Casani A, Battaglia A.
    Arch Gerontol Geriatr Suppl; 2004 Mar; (9):163-70. PubMed ID: 15207410
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the efficacy and tolerance of naftidrofuryl in patients presenting with exertional angina. Multicenter double-blind versus placebo study].
    Hirsch JL, Bensoussan JJ, Mosnier M, Lehert P.
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):137-45. PubMed ID: 12555338
    [Abstract] [Full Text] [Related]

  • 12. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W, Hirche H, Barmeyer J, Schümichen C, Hoffmann G.
    Med Welt; 1979 Feb 16; 30(7):269-72. PubMed ID: 372733
    [No Abstract] [Full Text] [Related]

  • 13. Naftidrofuryl can enhance the quality of life in patients with intermittent claudication.
    Spengel F, Brown TM, Poth J, Lehert P.
    Vasa; 1999 Aug 16; 28(3):207-12. PubMed ID: 10483329
    [Abstract] [Full Text] [Related]

  • 14. [Transcutaneous measures of oxygen partial pressure and capillaroscopic parameters as affected by naftidrofuryl in patients with obliterative arteriopathies, Fontaine stages II-IV].
    Ranft J, Heidrich H, Lammersen T.
    J Mal Vasc; 1987 Aug 16; 12(1):78-81. PubMed ID: 3559415
    [Abstract] [Full Text] [Related]

  • 15. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A, De Martini D, Flore R, Gaetani E, Gasbarrini A, Gerardino L, Pola R, Santoliquido A, Serricchio M, Tondi P, Nolfe G.
    Drugs Exp Clin Res; 1999 Aug 16; 25(1):29-36. PubMed ID: 10337502
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of the analgesic effect of naftidrofuryl in permanent ischemia in patients with arterial diseases. Double-blind versus placebo study].
    Testart J, Guidicelli H, Glanddier G, Mosnier M.
    Ann Cardiol Angeiol (Paris); 1994 Nov 16; 43(9):542-7. PubMed ID: 7864561
    [Abstract] [Full Text] [Related]

  • 17. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication.
    Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum Ø, Jørgensen JJ, Lindahl AK, Arnesen H, Seljeflot I, Kroese AJ.
    Eur J Vasc Endovasc Surg; 2007 Jan 16; 33(1):3-12. PubMed ID: 17055756
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.